Skip to main content
BIONIME logo

BIONIME — Investor Relations & Filings

Ticker · 4737 ISIN · TW0004737002 TW Manufacturing
Open in API
Filings indexed 1,735 across all filing types
Latest filing 2023-04-10 Director's Dealing
Country TW Taiwan
Listing TW 4737

About BIONIME

www.bionime.com

Bionime Corporation is a biotechnology firm specializing in the research, design, and manufacturing of comprehensive blood glucose management systems. The company develops high-precision monitoring solutions for both personal home use and professional medical environments, including Blood Glucose Meters (BGM), Continuous Glucose Monitoring Systems (CGM), and Point-of-Care Testing (POCT). Under its proprietary brand, RIGHTEST, Bionime integrates medical, chemical, electronic, and precision machinery expertise to deliver products that rival international standards. A core component of its offering is a cloud-based management ecosystem powered by IoT digital solutions, which synchronizes medical data with patient care services. With over 480 core patents in CGM technology and a commitment to Industry 4.0 smart production, Bionime focuses on enhancing diabetes care through technical innovation and a human-centered approach to health monitoring.

Recent filings

Filing Released Lang Actions
112年03月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings and changes in share ownership by insiders such as directors, managers, and their related parties. It includes data on shares held, increases, decreases, and trust shares. This type of document is typical of insider share transactions disclosures, reporting personal share dealings by company directors and executives. There is no indication of financial statements, earnings data, or meeting results. The content matches the definition of Director's Dealing filings, which report personal share transactions by company directors and executives.
2023-04-10 Chinese
112年03月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, independent directors, general managers, and major shareholders. It provides specific data on share counts, pledged shares, and related percentages. The content focuses on insider shareholdings and pledging status rather than financial results, management changes, or meeting materials. This type of disclosure aligns with reporting of personal share transactions or holdings by company directors and executives. Given the detailed insider shareholding data and the absence of other report types, the document fits best under the category of Director's Dealing (DIRS). The document length is 3255 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full financial report.
2023-04-10 Chinese
112年3月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (華廣) providing information about fund loans and endorsement guarantees, all showing zero balances. It is a short, factual update without detailed financial statements or analysis. The content fits the profile of a regulatory announcement or compliance disclosure rather than a full financial report or other specific filing types. Given the short length (601 characters) and the nature of the content, it is best classified as a Regulatory Filing (RNS), which serves as a fallback for miscellaneous regulatory disclosures that do not fit other categories.
2023-04-10 Chinese
112年3月營業收入
Regulatory Filings Classification · 95% confidence The document is a financial summary report showing monthly and cumulative net operating revenue figures for a company named 華廣 for the period of March 2023 (民國112年03月). It includes percentage changes compared to the previous year and explanatory notes about accounting standards (IFRS) and reporting practices. The document is very short (773 characters) and does not contain detailed financial statements or comprehensive analysis. It appears to be a brief financial data disclosure rather than a full financial report or earnings release. There is no indication of it being an announcement of a report publication or a certification. Given the nature and length, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous filings that do not fit other specific categories.
2023-04-10 Chinese
111年第4季海外子公司投資
Regulatory Filings Classification · 95% confidence The document is a tabular disclosure of investment holdings and related financial figures for overseas subsidiaries of a listed company, including investment amounts, ownership percentages, and recognized investment gains or losses. It is relatively short (1006 characters) and appears to be a regulatory disclosure of investment details rather than a full financial report or announcement. There is no indication of it being an annual or interim report, earnings release, or other specific report type. It fits best as a Regulatory Filing (RNS) because it is a compliance disclosure of investment information without comprehensive financial statements or management discussion.
2023-03-20 Chinese
111年第4季大陸投資
Regulatory Filings Classification · 90% confidence The document is a detailed tabular disclosure of investment amounts and related financial data concerning investments in mainland China by the company 華廣. It includes specific financial figures, investment methods, and regulatory limits as per the Economic Ministry's Investment Commission. The document length is 1414 characters, which is relatively short, but it contains substantive financial data related to investments rather than just an announcement or a certification. The content is focused on investment disclosures rather than a full annual or quarterly report, audit, or earnings release. This type of detailed investment disclosure aligns best with Regulatory Filings (RNS), as it does not fit the definitions of other more specific categories like Annual Report, Interim Report, or Capital/Financing Update. It is a regulatory disclosure of investment information required by authorities, thus classified as RNS.
2023-03-20 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.